TITILOPE FASIPE to Transfusion Reaction
This is a "connection" page, showing publications TITILOPE FASIPE has written about Transfusion Reaction.
Connection Strength
0.268
-
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series. Pediatr Blood Cancer. 2024 Aug; 71(8):e31061.
Score: 0.212
-
Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome. Transfusion. 2025 May; 65(5):1001-1006.
Score: 0.056